2002 Fall ADRC Meeting

Note: Following are links to available presentations from the meeting. The full agendas can be found here.

Directors Meeting

Discussion: Proxy Consent.
Leon Thal, MD — Director, University of California, San Diego
Scientific Symposium: Developing Technologies and New Approaches for Uncovering Genetic Mechanisms in Alzheimer’s Disease
Gene Array Technology: Identification of Novel Genes Involved in AD Pathogenesis.
David Goldman, MD — Chief of Laboratory Neurogenetics, National Institute on Alcohol Abuse and Alcoholism
The Study of Single Nucleotide Polymorphisms and Their Role in AD.
Jurg Ott, PhD — Professor and Head, Laboratory of Statistical Genetics, Rockefeller University
Informatics: Application of Information Sciences to Analysis and Interpretation of Novel Genetic Data.
Christopher Dubay, PhD — Assistant Professor, Division of Medical Informatics and Department of Medical and Molecular Genetics, Oregon Health and Science University
Early Lessons from Human AD Gene Expression Studies — Perspectives from the ADRCs.
Patricia Kramer, PhD — Professor, Departments of Neurology and Medical and Molecular Genetics, Oregon Health and Science University

NACC Presentations

Development and Use of the NACC Neuropathology Form.
Elizabeth Cochran, MD — Chair, ADRC Neuropathology Steering Committee; Rush-Presbyterian-St. Luke's Medical Center

Administrators Meeting

Surrogate Consent and Decision-Making Capacity Assessment.
Daniel Marson, PhD — University of Alabama at Birmingham
Research under the Health Insurance Portability and Accountability Act of 1996 (HIPAA).
Jeffrey P. Davis, JD, LLM — Associate Vice President for HIPAA Compliance and Privacy Officer, Columbia University, Health Sciences Division

Education Core Leaders Meeting

Health First.
Cathleen Connell, PhD